Currently, new forms of treatment (such as the combination therapy of interferon-α with lamivudine for patients who failed interferon-α monotherapy) are under investigation.<unk>  studies and monitoring are required to evaluate the genotypic resistance of HBV to nucleoside and nucleotide therapy.
Hepatitis B future or investigational therapies
Hepatitis C future or investigational therapies
Hepatitis E future or investigational therapies
Hepatitis D future or investigational therapies
Hepatitis B secondary prevention
Hepatitis B primary prevention
Hepatitis C primary prevention
Hepatitis E primary prevention